1. Home
  2. INSM vs TEAM Comparison

INSM vs TEAM Comparison

Compare INSM & TEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$165.46

Market Cap

41.2B

Sector

Health Care

ML Signal

HOLD

Logo Atlassian Corporation

TEAM

Atlassian Corporation

HOLD

Current Price

$164.66

Market Cap

44.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSM
TEAM
Founded
1988
2002
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.2B
44.6B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
INSM
TEAM
Price
$165.46
$164.66
Analyst Decision
Strong Buy
Buy
Analyst Count
21
27
Target Price
$188.05
$250.54
AVG Volume (30 Days)
3.1M
2.4M
Earning Date
10-30-2025
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$447,022,000.00
$5,460,076,000.00
Revenue This Year
$43.10
$23.41
Revenue Next Year
$128.25
$18.57
P/E Ratio
N/A
N/A
Revenue Growth
30.34
19.51
52 Week Low
$60.40
$139.70
52 Week High
$212.75
$326.00

Technical Indicators

Market Signals
Indicator
INSM
TEAM
Relative Strength Index (RSI) 28.92 62.95
Support Level $192.50 $157.12
Resistance Level $205.23 $166.48
Average True Range (ATR) 7.18 5.16
MACD -3.77 1.02
Stochastic Oscillator 6.57 92.03

Price Performance

Historical Comparison
INSM
TEAM

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About TEAM Atlassian Corporation

Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.

Share on Social Networks: